Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Carlsmed Q3 EPS $(0.40), Inline, Sales $13.074M Beat $11.398M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:01pm
Carlsmed (NASDAQ:CARL) reported quarterly losses of $(0.40) per share which met the analyst consensus estimate. This is a 80.58 percent increase over losses of $(2.06) per share from the same period last year. The company reported quarterly sales of $13.074 million which beat the analyst consensus estimate of $11.398 million by 14.71 percent. This is a 98.39 percent increase over sales of $6.590 million the same period last year.

Posted In: CARL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist